The Supreme Court decision over Baraclude established a ground for the patent acceptance of usage and volume
The hepatitis type B treatment ‘Baraclude’ patent suit, won by Jeil Pharm on the last 21st, has attracted interests of the pharmaceutical industry as founding a ground for pharmaceutical products to be accepted in usage and volume patents.
Based on the decision, multinational pharmaceutical comp...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
